Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Hepatocellular carcinoma risk prediction and early detection in patients with metabolic dysfunction associated steatotic liver disease

Translational Gastroenterology and Hepatology(2024)10.21037/tgh-24-41Source: DataRank Database

Hepatocellular carcinoma risk prediction and early detection in patients with metabolic dysfunction associated steatotic liver disease is a research paper published in Translational Gastroenterology and Hepatology (2024). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 4.53)OA: goldTopics (19)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Naomy Kim ORCID,Ju Dong Yang ORCID,Jeff Liang ORCID

Live enrichment

PubMed:39503040 PMC:PMC11535805 OpenAlex:https://openalex.org/W4403503844

National Institutes of Health

Grant: 5K08CA259534-02

Novel circulating biomarker digital scores for assessing treatment response in liver cancer

National Institutes of Health

Grant: 1R21CA280444-01

Novel circulating biomarker digital scores for assessing treatment response in liver cancer

FWCI

4.53

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.21037/tgh-24-41

publisherhttps://doi.org/10.21037/tgh-24-41

publisherhttps://tgh.amegroups.com/article/download/9094/pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39503040

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11535805

Fields of Study

Liver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseAlcohol Consumption and Health Effects0303 health sciences03 medical and health sciences

Keywords

MedicineHepatocellular carcinomaDiseaseInternal medicineCarcinomaGastroenterologyFatty liverOncologyHepatocellular carcinoma (HCC)Non-alcoholic Fatty Liver Disease (Nafld)Non-alcoholic Steatohepatitis (Nash)Metabolic Dysfunction-associated Steatohepatitis (Mash)Metabolic Dysfunction-associated Steatotic Liver Disease (Masld)Review Article

Sustainable Development Goals

SDG 0: Good health and well-being